Moderna, Inc.

Moderna entered a settlement with Arbutus/Genevant to resolve patent litigation, with Moderna making a $950M payment and potential $1.3B contingent payment. The agreement includes licenses, covenants, and releases.

Moderna, Inc. MRNA is headquartered in Cambridge, MA.

Source